CN111905072A - Clove antibacterial powder and preparation method thereof - Google Patents
Clove antibacterial powder and preparation method thereof Download PDFInfo
- Publication number
- CN111905072A CN111905072A CN202010690908.5A CN202010690908A CN111905072A CN 111905072 A CN111905072 A CN 111905072A CN 202010690908 A CN202010690908 A CN 202010690908A CN 111905072 A CN111905072 A CN 111905072A
- Authority
- CN
- China
- Prior art keywords
- parts
- clove
- root
- powder
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The invention discloses clove antibacterial powder and a preparation method thereof, wherein the clove antibacterial powder is prepared from the following raw materials in parts by weight: 1-3 parts of crinis carbonisatus, 1-3 parts of rehmannia root, 1-3 parts of myrrh, 1-3 parts of safflower, 1-3 parts of clove, 1-3 parts of rhizoma kaempferiae, 1-3 parts of magnolia flower, 1-3 parts of borneol, 1-3 parts of elecampane, 1-3 parts of red paeony root, 1-3 parts of peach kernel, 1-3 parts of teasel root, 1-3 parts of szechuan lovage rhizome, 1-3 parts of radix achyranthis bidentatae, 1-3 parts of raw kusnezoff monkshood root, 1-3 parts of frankincense and 1-3 parts of asarum. The clove antibacterial powder disclosed by the invention has the advantages that through mutual matching and synergistic effect of the raw materials, the medicinal effect is enhanced, the meridian dredging effect is improved, and the purposes of promoting blood circulation to remove blood stasis, diminishing inflammation and relieving pain, resisting aging, enhancing immunity, strengthening muscles and bones and strengthening waist and knees are achieved; the clove antibacterial powder has obvious curative effects on general aching pain, heaviness of muscles and bones, swelling, aching symptom, qi stagnation and blood stasis, cold limbs, numbness of legs and other symptoms caused by meridian obstruction.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, and particularly relates to clove antibacterial powder and a preparation method thereof.
Background
The meridians and collaterals connect the viscera throughout the body, play a role in communicating qi and blood, and are closely related to the occurrence and development of diseases. The abnormal function of the meridians and collaterals is easily affected by the pathological changes between the internal organs and the body surface tissues caused by the exogenous pathogenic factors from the exterior to the interior. Sufficient qi and blood is beneficial to the smooth circulation of meridians and collaterals, so that the meridians and collaterals are smooth, the viscera can have strong functions, and the immunity can be enhanced. On the contrary, when the meridians are obstructed and the zang-fu organs are weak, the toxin in the body cannot be cleared in time, and the external pathogenic factors cannot be effectively resisted.
The patients with meridian obstruction can firstly show pain, and typical symptoms comprise general aching pain, heavy bones and muscles, swelling, aching pain, qi stagnation and blood stasis, cold limbs, numbness of legs and the like. Most of the meridian dredging medicines on the market have long treatment period, poor treatment effect and even side effect.
Disclosure of Invention
Aiming at the technical problems in the related art, the invention provides clove bacteriostatic powder and a preparation method thereof, which can overcome the defects in the prior art.
In order to achieve the technical purpose, the technical scheme of the invention is realized as follows:
the clove antibacterial powder is prepared from the following raw materials in parts by weight: 1-3 parts of crinis carbonisatus, 1-3 parts of rehmannia root, 1-3 parts of myrrh, 1-3 parts of safflower, 1-3 parts of clove, 1-3 parts of rhizoma kaempferiae, 1-3 parts of magnolia flower, 1-3 parts of borneol, 1-3 parts of elecampane, 1-3 parts of red paeony root, 1-3 parts of peach kernel, 1-3 parts of teasel root, 1-3 parts of szechuan lovage rhizome, 1-3 parts of radix achyranthis bidentatae, 1-3 parts of raw kusnezoff monkshood root, 1-3 parts of frankincense and 1-3 parts of asarum.
Preferably, the clove antibacterial powder is prepared from the following raw materials in parts by weight: 3 parts of crinis carbonisatus, 3 parts of rehmannia root, 3 parts of myrrh, 3 parts of safflower, 3 parts of clove, 3 parts of rhizoma kaempferiae, 3 parts of biond magnolia flower, 1 part of borneol, 1 part of costustoot, 1 part of red paeony root, 1 part of peach kernel, 1 part of teasel root, 2 parts of szechuan lovage rhizome, 2 parts of radix achyranthis bidentatae, 2 parts of raw kusnezoff monkshood root, 2 parts of frankincense and 2 parts of asarum.
According to another aspect of the present invention, there is provided a method for preparing the above clove bacteriostasis powder, comprising the following steps:
(1) mixing crinis Carbonisatus, rehmanniae radix, Myrrha, Carthami flos, flos Caryophylli, rhizoma Kaempferiae, flos Magnoliae, Borneolum Syntheticum, radix aucklandiae, radix Paeoniae Rubra, semen Persicae, radix Dipsaci, rhizoma Ligustici Chuanxiong, Achyranthis radix, radix Aconiti Kusnezoffii, Olibanum, and herba asari at a certain ratio, and pulverizing to obtain powder;
(2) and (3) coating the powder obtained in the step (1) to obtain the clove antibacterial powder.
Preferably, the fineness of the powder is 100-300 mesh.
Preferably, the powder in step (2) is wrapped with gauze.
Carbonized human hair: enter liver and stomach meridians, astringe to stop bleeding, resolve blood stasis and induce diuresis.
Rehmannia root: has effects of clearing heat, promoting fluid production, and cooling blood.
Myrrh: bitter in property, pungent and even in property, and has the effects of activating blood, relieving pain, reducing swelling and promoting tissue regeneration, and the spleen meridian entered.
Safflower: warm in nature, pungent in flavor, promoting blood circulation, dredging meridian, removing blood stasis and relieving pain.
Clove: has antibacterial and bactericidal effects, and oleum Caryophylli and eugenol have broad-spectrum antibacterial effect and can effectively inhibit Staphylococcus, Escherichia coli, helicobacter pylori, streptococcus, etc.
And (3) rhizoma kaempferiae: pungent and warm. It enters spleen and stomach meridians, warms middle energizer to resolve dampness, and promotes qi circulation to alleviate pain.
And (3) magnolia flower: pungent and warm. It enters lung and stomach meridians, and dispels wind-cold, unblocks nasal orifices.
Borneol: pungent, bitter and slightly cold in flavor; heart, liver and lung meridians entered; has effects of inducing resuscitation, refreshing mind, clearing away heat, removing toxic substances, improving eyesight, and eliminating nebula.
Costustoot: pungent, bitter and warm in nature, and has effects of activating qi-flowing, relieving pain, invigorating spleen and resolving food stagnation.
Red peony root: bitter and slightly cold; entering liver meridian; has the effects of clearing heat, cooling blood, promoting blood circulation and removing blood stasis.
Peach kernel: has effects in promoting blood circulation, dispelling blood stasis, loosening bowel to relieve constipation, and relieving cough and asthma.
Teasel root: slightly warm in nature, bitter and pungent in flavor; it enters liver and kidney meridians. Has effects in nourishing liver and kidney, strengthening muscle and bone, promoting fracture, and preventing metrorrhagia.
Ligusticum wallichii: it has inhibitory effect on large intestine, dysentery (Sonne), deformity, pyocyania, typhoid fever, Bacillus paratyphi and Vibrio cholerae. The rhizoma Ligustici Chuanxiong water infusion also has inhibitory effect on certain pathogenic dermatophytes.
Achyranthes bidentata: has effects of removing blood stasis, dredging channels, nourishing liver and kidney, strengthening tendons and bones, inducing diuresis, promoting blood circulation, and can be used for treating edema of lower limbs, swelling and pain of knee joint, etc.
Raw kusnezoff monkshood root: the main effects of dispelling wind and eliminating dampness, warming and activating meridian, dispelling cold and reducing swelling and relieving pain, can be used for treating pain of each joint caused by wind-cold-dampness arthralgia, and can be used for treating traumatic injury, blood stasis swelling and pain, sore and carbuncle pyogenic infections; can also be used for treating apoplexy, hemiplegia, headache, etc.
Frankincense: regulating qi and promoting blood circulation, relieving pain, removing toxic substance, and treating stagnation of qi and blood, pain of heart and abdomen, carbuncle, sore, toxic swelling, traumatic injury, dysmenorrhea, and puerperal blood stasis and pain.
Asarum: has the functions of expelling wind, dispelling cold, promoting diuresis, inducing resuscitation, etc. It is commonly used for wind-cold headache, nasosinusitis, toothache, phlegm-fluid cough, wind-damp arthralgia, etc.
The invention has the beneficial effects that: the clove antibacterial powder disclosed by the invention has the advantages that through mutual matching and synergistic effect of the raw materials, the medicinal effect is enhanced, the meridian dredging effect is improved, and the purposes of promoting blood circulation to remove blood stasis, diminishing inflammation and relieving pain, resisting aging, enhancing immunity, strengthening muscles and bones and strengthening waist and knees are achieved; the clove antibacterial powder has obvious curative effects on general aching pain, heavy muscles and bones, swelling, aching pain caused by meridian obstruction, and symptoms such as qi stagnation and blood stasis, cold limbs, numbness of legs and the like.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments that can be derived by one of ordinary skill in the art from the embodiments given herein are intended to be within the scope of the present invention.
Example 1
The clove antibacterial powder is prepared from the following raw materials: carbonized human hair 3g, rehmannia root 3g, myrrh 3g, safflower 3g, clove 3g, kaempferia galamga 3g, magnolia flower 3g, borneol 1g, banksia rose 1g, red peony root 1g, peach kernel 1g, dipsacus root 1g, Ligusticum wallichii 2g, achyranthes and cyathula root 2g, Kusnezoff monkshood root 2g, frankincense 2g and asarum herb 2 g.
The preparation method of the clove antibacterial powder comprises the following steps:
(1) uniformly mixing 3g of carbonized human hair, 3g of rehmannia root, 3g of myrrh, 3g of safflower, 3g of clove, 3g of rhizoma kaempferiae, 3g of magnolia flower, 1g of borneol, 1g of costustoot, 1g of red paeony root, 1g of peach kernel, 1g of teasel root, 2g of szechuan lovage rhizome, 2g of radix achyranthis bidentatae, 2g of raw kusnezoff monkshood root, 2g of frankincense and 2g of asarum, and then crushing to obtain powder, wherein the fineness of the powder is 100 meshes;
(2) and (3) wrapping the powder obtained in the step (1) with gauze to obtain the clove antibacterial powder.
Example 2
The clove antibacterial powder is prepared from the following raw materials: 3g of carbonized human hair, 3g of rehmannia root, 3g of myrrh, 3g of safflower, 3g of clove, 3g of rhizoma kaempferiae, 3g of biond magnolia flower, 3g of borneol, 3g of costustoot, 3g of red paeony root, 3g of peach kernel, 3g of teasel root, 3g of szechuan lovage rhizome, 3g of radix achyranthis bidentatae, 3g of raw kusnezoff monkshood root, 3g of frankincense and 3g of asarum.
The preparation method of the clove antibacterial powder comprises the following steps:
(1) uniformly mixing 3g of carbonized human hair, 3g of rehmannia root, 3g of myrrh, 3g of safflower, 3g of clove, 3g of rhizoma kaempferiae, 3g of magnolia flower, 3g of borneol, 3g of costustoot, 3g of red paeony root, 3g of peach kernel, 3g of teasel root, 3g of szechuan lovage rhizome, 3g of radix achyranthis bidentatae, 3g of raw kusnezoff monkshood root, 3g of frankincense and 3g of asarum, and then crushing to obtain powder, wherein the fineness of the powder is 300 meshes;
(2) and (3) wrapping the powder obtained in the step (1) with gauze to obtain the clove antibacterial powder.
Example 3
The clove antibacterial powder is prepared from the following raw materials: 1g of carbonized human hair, 1g of rehmannia root, 1g of myrrh, 1g of safflower, 1g of clove, 1g of rhizoma kaempferiae, 1g of magnolia flower, 1g of borneol, 1g of costustoot, 1g of red paeony root, 1g of peach kernel, 1g of teasel root, 1g of szechuan lovage rhizome, 1g of radix achyranthis bidentatae, 1g of raw kusnezoff monkshood root, 1g of frankincense and 1g of asarum.
The preparation method of the clove antibacterial powder comprises the following steps:
(1) uniformly mixing 1g of carbonized human hair, 1g of rehmannia root, 1g of myrrh, 1g of safflower, 1g of clove, 1g of rhizoma kaempferiae, 1g of magnolia flower, 1g of borneol, 1g of costustoot, 1g of red paeony root, 1g of peach kernel, 1g of teasel root, 1g of szechuan lovage rhizome, 1g of radix achyranthis bidentatae, 1g of raw kusnezoff monkshood root, 1g of frankincense and 1g of asarum, and then crushing to obtain powder, wherein the fineness of the powder is 200 meshes;
(2) and (3) wrapping the powder obtained in the step (1) with gauze to obtain the clove antibacterial powder.
Example 4
40 patients with symptoms of general aching pain, heavy bones and muscles, swelling, aching symptom, qi stagnation and blood stasis, cold limbs, numbness of legs and the like caused by meridian obstruction are selected, 21 male patients and 19 female patients respectively adopt the clove antibacterial powder prepared in the embodiment 1 to soak the affected part, and the specific method is that a proper amount of clear water is added into a clove antibacterial powder medicine bag, the clove antibacterial powder medicine bag is soaked for half an hour and then boiled with strong fire, the medicine bag is boiled with slow fire for half an hour to obtain medicine liquid, the medicine liquid is used to soak the affected part for 15 minutes after the temperature is adjusted, and the medicine liquid is used once every day and one bag every time for 45 days continuously.
The use effect is as follows: the cure rate is 85 percent, and the effective rate is 100 percent.
Cure means complete disappearance of symptoms, effective means some relief of symptoms, no change in symptoms is ineffective.
In conclusion, by means of the technical scheme, the raw materials are mutually matched and cooperate, so that the medicinal effect is enhanced, the channel dredging effect is improved, and the purposes of activating blood circulation to dissipate blood stasis, diminishing inflammation, relieving pain, resisting aging, enhancing immunity, strengthening the muscles and bones, and strengthening waist and knees are achieved.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (5)
1. The clove antibacterial powder is characterized by being prepared from the following raw materials in parts by weight: 1-3 parts of crinis carbonisatus, 1-3 parts of rehmannia root, 1-3 parts of myrrh, 1-3 parts of safflower, 1-3 parts of clove, 1-3 parts of rhizoma kaempferiae, 1-3 parts of magnolia flower, 1-3 parts of borneol, 1-3 parts of elecampane, 1-3 parts of red paeony root, 1-3 parts of peach kernel, 1-3 parts of teasel root, 1-3 parts of szechuan lovage rhizome, 1-3 parts of radix achyranthis bidentatae, 1-3 parts of raw kusnezoff monkshood root, 1-3 parts of frankincense and 1-3 parts of asarum.
2. The clove sterilization powder according to claim 1 is prepared from the following raw materials in parts by weight: 3 parts of crinis carbonisatus, 3 parts of rehmannia root, 3 parts of myrrh, 3 parts of safflower, 3 parts of clove, 3 parts of rhizoma kaempferiae, 3 parts of biond magnolia flower, 1 part of borneol, 1 part of costustoot, 1 part of red paeony root, 1 part of peach kernel, 1 part of teasel root, 2 parts of szechuan lovage rhizome, 2 parts of radix achyranthis bidentatae, 2 parts of raw kusnezoff monkshood root, 2 parts of frankincense and 2 parts of asarum.
3. A method for preparing the clove bacteriostat powder as claimed in claim 1 or 2, which comprises the following steps:
(1) mixing crinis Carbonisatus, rehmanniae radix, Myrrha, Carthami flos, flos Caryophylli, rhizoma Kaempferiae, flos Magnoliae, Borneolum Syntheticum, radix aucklandiae, radix Paeoniae Rubra, semen Persicae, radix Dipsaci, rhizoma Ligustici Chuanxiong, Achyranthis radix, radix Aconiti Kusnezoffii, Olibanum, and herba asari at a certain ratio, and pulverizing to obtain powder;
(2) and (3) coating the powder obtained in the step (1) to obtain the clove antibacterial powder.
4. The method as claimed in claim 3, wherein the powder has a fineness of 100-300 mesh.
5. The method of claim 3, wherein the powder in step (2) is wrapped with gauze.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010690908.5A CN111905072A (en) | 2020-07-17 | 2020-07-17 | Clove antibacterial powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010690908.5A CN111905072A (en) | 2020-07-17 | 2020-07-17 | Clove antibacterial powder and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111905072A true CN111905072A (en) | 2020-11-10 |
Family
ID=73281877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010690908.5A Pending CN111905072A (en) | 2020-07-17 | 2020-07-17 | Clove antibacterial powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111905072A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1115645A (en) * | 1994-01-29 | 1996-01-31 | 白文甫 | Detumescent anodyne slurry |
CN1285196A (en) * | 2000-08-28 | 2001-02-28 | 赵芳可 | Shubi plaster for treating arthralgia due to wind-cold-dampness |
CN1331981A (en) * | 2000-11-27 | 2002-01-23 | 中山市中医院 | Medicine for treating traumatic injury and relieving pain |
CN102688450A (en) * | 2012-06-01 | 2012-09-26 | 王会 | Local use antalgic traditional Chinese medicine composition as well as preparation method and application thereof |
CN108498593A (en) * | 2018-06-25 | 2018-09-07 | 高金儿 | A kind of Chinese medicine composition for treating neck-shoulder pain, lumbago and leg pain |
-
2020
- 2020-07-17 CN CN202010690908.5A patent/CN111905072A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1115645A (en) * | 1994-01-29 | 1996-01-31 | 白文甫 | Detumescent anodyne slurry |
CN1285196A (en) * | 2000-08-28 | 2001-02-28 | 赵芳可 | Shubi plaster for treating arthralgia due to wind-cold-dampness |
CN1331981A (en) * | 2000-11-27 | 2002-01-23 | 中山市中医院 | Medicine for treating traumatic injury and relieving pain |
CN102688450A (en) * | 2012-06-01 | 2012-09-26 | 王会 | Local use antalgic traditional Chinese medicine composition as well as preparation method and application thereof |
CN108498593A (en) * | 2018-06-25 | 2018-09-07 | 高金儿 | A kind of Chinese medicine composition for treating neck-shoulder pain, lumbago and leg pain |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104644943A (en) | Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method | |
CN108619478A (en) | A kind of Chinese medicine preparation for treating treating rheumatic ostealgia | |
CN102626505B (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
CN102961483B (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
CN102008674B (en) | Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof | |
CN103263601A (en) | Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation | |
CN103330873B (en) | Snake wound rehabilitation medicament | |
CN111905072A (en) | Clove antibacterial powder and preparation method thereof | |
CN105770796A (en) | Medicinal liquor liniment for treating soft tissue injury | |
CN102824421B (en) | Method for preparing Chinese medicinal lotion for treating surprised type closed fracture | |
CN105311520A (en) | Traditional Chinese medicine liniment for treating traumatic injuries | |
CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
CN104189320A (en) | Externally-applied traditional Chinese medicine preparation for treating traumatic injury | |
CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
CN116098976B (en) | Medicinal liquor for relaxing muscles, activating blood circulation, detumescence and relieving pain | |
CN109394928A (en) | A kind of moxibustion liquid and preparation method thereof | |
CN103550471A (en) | Traditional Chinese medicine (TCM) composition for treating Bi pain | |
CN102631631A (en) | Preparation method for traditional Chinese medicine for treating abdominal pain type colitis | |
CN112933205A (en) | Pharmaceutical composition for treating osteoarthritis and preparation method thereof | |
CN114272314A (en) | Fumigation medicine for treating pain and its preparing method and use | |
CN104147234A (en) | External traditional Chinese medicinal application composition for treating neck-shoulder and lumbocrural pains | |
CN103877296A (en) | Oral traditional Chinese medicine powder and external application medicine for treating burns and scalds | |
CN112043803A (en) | Antibacterial frankincense paste | |
CN105079522A (en) | Medicine for treating chronic prostatitis | |
CN116672428A (en) | Traditional Chinese medicine composition for treating wind-cold osteodynia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201110 |
|
RJ01 | Rejection of invention patent application after publication |